Меню
Идёт набор NCT06429969

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Наблюдательное Vitreoretinal Disease

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Vitreoretinal Disease. Базовые параметры: 40 лет — 90 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Nuclear Magnetic Resonance (NMR)-Based Metabolomic Characterisation of Vitreoretinal Diseases Using Vitreous Fluid

Обзор

The goal of this observational study was to learn about metabolomics profiles in vitreoretinal diseases by nuclear magnetic resonance (NMR)using vitreous fluid. The main question it aimed to answer was abnormal biomarkers for common retinal diseases such as idiopathic macular hole(IMH), diabetic retinopathy(DR) and retinal detachment(RD). Participants would not be subjected to any intervention and the investigators would only collect preoperative information and remaining vitreous samples. The investigators divided the participants into groups with appropriate disease names based on the disease diagnosis, such as IMH group, DR group, and RD group. The MH group was used as a control group, investigators compared other groups to see the metabolomic abnormalities.

Подробное описание

This study aimed to analyze vitreous fluid using NMR to discover potential biomarkers for the prevention, early diagnosis, and treatment of vitreoretinal diseases and to reveal the mechanisms of disease progression. Patients suffering from IMH, DR, RD, idiopathic macular epiretinal membrane (IMM), and retinal vein occlusion (RVO) quiring for pars plana vitrectomy (PPV), who visited Renmin Hospital of Wuhan University, were chosen to participate in this study. Participants were not subjected to any intervention and the investigator only collected preoperative information and remaining vitreous samples. Participants provided preoperative examination information and medical history, and the investigators divided the participants into five groups with corresponding disease names based on the disease diagnosis, including five groups for five diseases: IMH group, DR group, RD group, IMM group, and RVO group. The control group for the diseases was the IMH group, and metabolomic differences were observed. These patients are usually treated with PPV, during PPV typically performed on these patients, vitreous fluid is usually disposed of as waste, and investigators collected 100-250 ul of the fluid for NMR analysis to see metabolomic characterization of these diseases.

Первичные конечные точки

  • Relative amino acid concentration(Unite: %) [Срок оценки: intraoperative]
Вторичные конечные точки (1)
  • Relative concentrations of macromolecules such as glucose and lipids(Unite: %) [Срок оценки: intraoperative]

Критерии участия

Критерии включения

  • Confirmation of IMH diagnosis with concomitant need for PPV surgery;
  • Confirmation of DR diagnosis with concomitant need for PPV surgery;
  • Confirmation of RD diagnosis with concomitant need for PPV surgery;
  • Confirmation of IMM diagnosis with concomitant need for PPV surgery;
  • Confirmation of RVO diagnosis with concomitant need for PPV surgery.

Критерии исключения

  • Diagnosed vitreoretinal disease with no need for PPV surgery;
  • Previous history of PPV surgery;
  • Combination of other active ophthalmic diseases, such as acute conjunctivitis and uveitis;
  • Combination of serious systemic diseases such as hypertension and diabetes mellitus.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Случай-контроль

Центры проведения

Китай · 1 центр
  • Eye, Center, Renmin Hospital of Wuhan University — Ухань

Идентификаторы

NCT: NCT06429969 · WDRY2022-K222

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗